Melissa Marshall v. HHS - Tdap, shoulder injury related to vaccine administration (SIRVA) (2025)
Case summary [AI summaries can sometimes make mistakes]
Melissa Marshall filed a petition for compensation under the National Vaccine Injury Compensation Program on May 23, 2023. She alleged that on May 4, 2021, she received a tetanus-diphtheria-acellular pertussis (Tdap) vaccine, which is listed on the Vaccine Injury Table.
Petitioner claimed she sustained a shoulder injury related to vaccine administration (SIRVA) within the time period specified by the Table and experienced residual effects of this condition for more than six months. The respondent denied that Petitioner sustained a SIRVA Table injury, that the vaccine caused her alleged shoulder injury, or that her current condition was a sequela of a vaccine-related injury.
Despite these denials, the parties filed a joint stipulation for compensation on May 14, 2025. Chief Special Master Brian H.
Corcoran found the stipulation reasonable and adopted it as the decision awarding damages. The decision awarded Melissa Marshall a lump sum of $24,000.00, to be paid via ACH deposit to Petitioner's counsel's IOLTA account for prompt disbursement.
This amount represents compensation for all items of damages available under Section 15(a) of the Vaccine Act. Petitioner was represented by Ronald Craig Homer of Conway, Homer, P.C., and Respondent was represented by Eleanor Hanson of the U.S.
Department of Justice. The decision was issued on May 15, 2025.
Source PDFs
USCOURTS-cofc-1_23-vv-00756